IDXG首席执行官Thomas Burnell表示,随着交易的完成,公司的运营现金流预计每年将增加近500万美元,且将把出售所得用于满足营运资金需求,并用于投资发展分子诊断业务。
$药明康德(SH603259)$ $泰格医药(SZ...查看全文
不乱下2019-04-25 11:27
$Interpace诊断(IDXG)$ 从事于美国甲状腺癌/胰腺癌组织LDT基因诊断服务(不是液体活检),这是一家LDT服务商。 IDXG的主要产品都是并购过来的资产,所以这家公司的定位就是一个商业化公司而不是一个技术公司。 按照公司的说法,公司在甲状腺癌组织基因诊断服务方面技术上还是领先的,而胰腺癌好像...查看全文
$INTERPACE DIAGNOSTICS GROUP INC(IDXG)$ DEF 14A - Other definitive proxy statements Filed: 2016-06-22 AccNo: 0001437749-16-034255 Size: 2 MB 网页链接
$INTERPACE DIAGNOSTICS GROUP INC(IDXG)$ 8-K/A [Amend] - Current report Filed: 2016-06-22 AccNo: 0001437749-16-034253 Size: 153 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain...
$INTERPACE DIAGNOSTICS GROUP INC(IDXG)$ 10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2016-06-14 AccNo: 0001437749-16-033773 Size: 272 KB 网页链接
$INTERPACE DIAGNOSTICS GROUP INC(IDXG)$ PRE 14A - Other preliminary proxy statements Filed: 2016-06-10 AccNo: 0001437749-16-033688 Size: 1 MB 网页链接
$INTERPACE DIAGNOSTICS GROUP INC(IDXG)$ 8-K - Current report Filed: 2016-05-13 AccNo: 0001437749-16-031738 Size: 178 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$INTERPACE DIAGNOSTICS GROUP INC(IDXG)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2016-05-12 AccNo: 0001437749-16-031581 Size: 4 MB 网页链接
$INTERPACE DIAGNOSTICS GROUP INC(IDXG)$ 10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2016-04-29 AccNo: 0001437749-16-030358 Size: 557 KB 网页链接
$INTERPACE DIAGNOSTICS GROUP INC(IDXG)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2016-04-26 AccNo: 0000892712-16-001611 Size: 2 MB 网页链接
$INTERPACE DIAGNOSTICS GROUP INC(IDXG)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2016-04-06 AccNo: 0000892712-16-001587 Size: 41 KB 网页链接
$INTERPACE DIAGNOSTICS GROUP INC(IDXG)$ 8-K - Current report Filed: 2016-03-31 AccNo: 0001054102-16-000099 Size: 403 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接